Review



multiparameter optimization algorithm (cns mpo)  (Pfizer Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Pfizer Inc multiparameter optimization algorithm (cns mpo)
    Multiparameter Optimization Algorithm (Cns Mpo), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/multiparameter+optimization+algorithm/pmc08308832-678-23-17
    Average 90 stars, based on 1 article reviews
    multiparameter optimization algorithm (cns mpo) - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Establishment of a Structure–Activity Relationship of 1H-Imidazo[4,5-c]quinoline-Based Kinase Inhibitor NVP-BEZ235 as a Lead for African Sleeping Sickness
    Article Snippet: In evaluating analogue designs, we employed the multiparameter optimization (MPO) algorithm developed by Pfizer scientists aEC50 average was obtained from two replicates, with SD lower than 0.1 log. bTC50 average was obtained from two replicates, with SD lower than 0.5 log. cSelectivity = TC50/EC50. fStock concentration: 2.5 mM. gStock concentration: 1.25 mM. dx.doi.org/10.1021/jm500361r | J. Med.

    Article Title: Medicinal Chemistry strategies for PET tracer discovery.
    Article Snippet: The detection of gamma rays, resulting from decay of positron emitting isotopes, allows exquisitely sensitive detection of probes radiolabeled with such isotopes.. These probes can be designed for high affinity binding to specific molecular targets and be used as tools in the early development of drugs, particularly for neuropsychiatric disorders.. Availability of novel tracers requires dedicated resources and selection assays.

    Article Title: Establishment of a Structure–Activity Relationship of 1 H -Imidazo[4,5- c ]quinoline-Based Kinase Inhibitor NVP-BEZ235 as a Lead for African Sleeping Sickness
    Article Snippet: In evaluating analogue designs, we employed the multiparameter optimization (MPO) algorithm developed by Pfizer scientists for CNS-active drugs., This aforementioned publication showed a correlation between six fundamental physicochemical properties (cLogP, cLogD, MW, TPSA, hydrogen-bond donors, and the p K a of the most basic center) and their impact on CNS-acting agents as well as other critical ADME, toxicity, and binding efficiencies.

    Article Title: Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement
    Article Snippet: These compounds were designed to penetrate the blood–brain barrier by use of the Pfizer multiparameter optimisation (MPO) approach to CNS drug design , .

    Article Title: Synthesis, structural characterization, computational studies, and antifungal activity of isoniazid derivative
    Article Snippet: In this work, the isoniazid derivative N’,N’’’-((1E,1′E)-1,4-phenylenebis(methaneylylidene))di(isonicotinohydrazide) (BISHDZHI) was synthesized and characterized by Nuclear Magnetic Resonance (NMR), Attenuated Total Reflectance Fourier Transform Infrared spectroscopy (ATR-FTIR), Fourier Transform Raman (FT-Raman), and Ultraviolet-Visible (UV–Vis) spectroscopy, and its potential against fungal strains of Candida ssp. was evaluated by in vitro assays.. The NMR spectrum confirmed the molecular structure of BISHDZHI.. Quantum chemistry computational calculations allowed to obtain the potential energy surface, optimized molecular structure, and to identify all the bands of the Raman, infrared and UV spectra.

    Article Title: Structural modifications that alter the P-glycoprotein efflux properties of compounds.
    Article Snippet: Retrospective analysis of marketed drugs has revealed that very low prevalence of P-glycoprotein (P-gp) efflux and moderate to high passive permeability are two key properties that distinguish drugs which engage targets in the central nervous system (CNS) from those that act predominantly in the periphery.. Quantification of the efflux properties that differentiate CNS drugs has been determined using in vitro assays for human and rodent P-gp, and revealed in vivo by comparing brain drug exposures in P-gp (mdr1a/b(−/−)) knockout mice against those observed in wild type mice.. Recognition by P-gp not only dramatically affects the distribution properties of compounds into bodily compartments including the CNS, testis, and placenta but also confers resistance to certain cancer chemotherapeutics.

    Article Title: Strategies for Structural Modification of Small Molecules to Improve Blood-Brain Barrier Penetration: A Recent Perspective.
    Article Snippet: In the development of central nervous system (CNS) drugs, the blood−brain barrier (BBB) restricts many drugs from entering the brain to exert therapeutic effects.. Although many novel delivery methods of large molecule drugs have been designed to assist transport, small molecule drugs account for the vast majority of the CNS drugs used clinically.. From this perspective, we review studies from the past five years that have sought to modify small molecules to increase brain exposure.

    Permeability:

    Article Title: Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma
    Article Snippet: .. An algorithm including six physicochemical parameters for assessing the BBB permeability of CNS drugs was devised by Pfizer and is known as the multiparameter optimization algorithm (CNS MPO). ..



    Similar Products

    90
    Pfizer Inc cns multiparameter optimization (cns mpo) algorithm
    Cns Multiparameter Optimization (Cns Mpo) Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/cns+multiparameter+optimization++cns+mpo++algorithm/pm40339216-51-9-6
    Average 90 stars, based on 1 article reviews
    cns multiparameter optimization (cns mpo) algorithm - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Pfizer Inc central nervous system multiparameter optimization (cns mpo) algorithm
    Central Nervous System Multiparameter Optimization (Cns Mpo) Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/cns+multiparameter+optimization++cns+mpo++algorithm/pm40198203-196-1-11
    Average 90 stars, based on 1 article reviews
    central nervous system multiparameter optimization (cns mpo) algorithm - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Pfizer Inc weighted scoring approach, called “cns mpo (multiparameter optimization)” algorithm
    Weighted Scoring Approach, Called “Cns Mpo (Multiparameter Optimization)” Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/cns+mpo/pmc10546485-73-19-12
    Average 90 stars, based on 1 article reviews
    weighted scoring approach, called “cns mpo (multiparameter optimization)” algorithm - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Pfizer Inc drug-likeness central nervous system multiparameter optimization (cns mpo) algorithm
    Drug Likeness Central Nervous System Multiparameter Optimization (Cns Mpo) Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/drug+likeness+central+nervous+system+multiparameter+optimization++cns+mpo++algorithm/pm34653944-90-13-25
    Average 90 stars, based on 1 article reviews
    drug-likeness central nervous system multiparameter optimization (cns mpo) algorithm - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Pfizer Inc multiparameter optimization algorithm (cns mpo)
    Multiparameter Optimization Algorithm (Cns Mpo), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/multiparameter+optimization+algorithm/pmc08308832-678-23-17
    Average 90 stars, based on 1 article reviews
    multiparameter optimization algorithm (cns mpo) - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Pfizer Inc druglikeness cns multiparameter optimization (cns mpo) algorithm
    Druglikeness Cns Multiparameter Optimization (Cns Mpo) Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/cns+multiparameter+optimization++cns+mpo++algorithm/pm31050421-181-3-12
    Average 90 stars, based on 1 article reviews
    druglikeness cns multiparameter optimization (cns mpo) algorithm - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results